Leerink Partnrs Predicts Revvity's Q2 Earnings (NYSE:RVTY)

Revvity Inc. (NYSE:RVTY - Free Report) - Equities researchers at Leerink Partnrs lowered their Q2 2026 EPS estimates for Revvity in a report issued on Monday, June 23rd. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings per share of $1.41 for the quarter, down from their prior estimate of $1.43. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q4 2026 earnings at $1.69 EPS and FY2026 earnings at $5.61 EPS.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The business's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.98 EPS.

Several other research firms have also recently issued reports on RVTY. Wall Street Zen raised shares of Revvity from a "hold" rating to a "buy" rating in a research report on Saturday. Robert W. Baird decreased their price target on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. The Goldman Sachs Group lowered their price objective on shares of Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. cut their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. Finally, Bank of America lowered their price target on Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research report on Thursday. Four investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $123.64.

Revvity Trading Down 1.0%

NYSE RVTY traded down $1.01 during trading hours on Wednesday, hitting $97.78. 1,331,016 shares of the company's stock were exchanged, compared to its average volume of 971,406. Revvity has a 12-month low of $87.70 and a 12-month high of $129.50. The business's 50 day moving average is $93.36 and its 200-day moving average is $105.45. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.99 and a current ratio of 3.58. The firm has a market capitalization of $11.53 billion, a P/E ratio of 41.61, a price-to-earnings-growth ratio of 2.41 and a beta of 0.97.

Institutional Investors Weigh In On Revvity

Large investors have recently modified their holdings of the stock. Assetmark Inc. boosted its holdings in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after acquiring an additional 259 shares during the period. Optiver Holding B.V. acquired a new position in shares of Revvity during the fourth quarter worth $33,000. Quarry LP boosted its stake in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after purchasing an additional 95 shares during the period. Millstone Evans Group LLC purchased a new position in shares of Revvity in the fourth quarter valued at $38,000. Finally, Vermillion Wealth Management Inc. acquired a new stake in Revvity during the 4th quarter valued at $41,000. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.